TB-500 Dubai: Research Vial and Thymosin Beta-4 Guide
TB-500 search demand clusters around buy intent, thymosin beta-4 identity, and Dubai availability. This article supports the 10mg product page by separating synthetic research-vial labeling from the broader thymosin beta-4 literature.
Update History ▾
Research-use-only framing applied throughout in line with Remy editorial standards.
TB-500 search demand clusters around buy intent, thymosin beta-4 identity, and Dubai availability. This article supports the 10mg product page by separating synthetic research-vial labeling from the broader thymosin beta-4 literature. Remy Peptides currently lists TB-500 10mg Vial as In stock, with 10mg · Lyophilized research vial and AED 290-350 pricing shown in the product catalog. This article supports the product page with evidence context, local Dubai/UAE search routing, and COA verification language only.
Why This Product-Support Guide Exists
Researchers comparing TB-500 suppliers should verify vial format, AED price tier, COA availability, and whether the seller distinguishes the market fragment from full-length thymosin beta-4.
This guide answers common local research-supply searches such as:
- buy tb 500
- tb 500
- tb-500 dubai
- tb 500 peptide dubai
- thymosin beta 4
For current product facts, start with TB-500 10mg Vial. This article adds the surrounding evidence, supplier-verification, and compliance context around that listing.
Evidence Map and Translation Limits
Thymosin beta-4 is a 43-amino-acid actin-sequestering protein with a large repair-biology literature, while TB-500 in research catalogs is generally discussed as a synthetic Tβ4-derived fragment rather than the full native protein.[1] Clinical-trial searches around ophthalmic Tβ4 formulations help explain the evidence boundary but do not validate retail research-vial claims.[2]
| Research layer | What the literature supports | How it should inform the product page |
|---|---|---|
| Identity boundary | Full-length thymosin beta-4 and market TB-500 fragment language should not be collapsed into one product claim. | Prevents overclaiming on the product page. |
| Evidence tier | The actin-binding literature is mechanistic and model-heavy; human clinical work is concentrated in specific regulated formulations. | Keeps the article useful without becoming a clinical-use guide. |
| Dubai product intent | The local query wants a 10mg vial, price range, stock status, and COA route. | Routes to /product/tb-500-10mg as the owner page. |
Dubai/UAE Product Documentation
For commercial clarity, the live product page remains the source of truth. This article mirrors only stable catalog facts and points researchers back to the current listing before any order or restock check.
| Field | Current Remy Peptides listing |
|---|---|
| Product page | TB-500 10mg Vial |
| Format | 10mg · Lyophilized research vial |
| Stock status | In stock |
| AED price tier | AED 290-350 |
| COA route | Check the product page and COA library; request lot-specific HPLC documentation when a public batch file is not yet posted. |
| Use restriction | For in-vitro laboratory research only. Not for human or veterinary use. |
Supplier Checks for Research-Use Buyers
For Dubai and UAE research-supply searches, the cleanest buying checklist is evidence-light and verification-heavy. Before comparing any TB-500 10mg source, confirm:
- The seller gives a stable product URL with vial size, format, price tier, and stock status.
- The page states Research Use Only and avoids human-use, veterinary-use, diagnostic, therapeutic, or disease-management claims.
- COA language is batch-specific, with HPLC purity and identity documentation available before purchase or on request.
- Cold-chain handling and official-contact verification are clear enough to reduce impersonation and gray-market risk.
Remy Peptides centralizes that workflow through the product page, the COA library, and contact verification.
What This Page Does Not Claim
The research record helps define the compound, but it does not turn an RUO vial into a clinical product. Keep these boundaries in view:
- Avoid injury-recovery or tissue-repair promises in commercial copy.
- Do not publish protocols, administration instructions, or human-use comparisons.
- Do not state that research TB-500 equals full-length clinical thymosin beta-4 formulations.
Our Research Standards
This article was built from local non-retatrutide search-demand review, existing Remy article standards, live product-catalog data, and peer-reviewed or official source checks. No therapeutic, human-use, or veterinary-use claim is made. Read our editorial policy →
TB-500 10mg Research FAQ
Can Dubai researchers buy TB-500 10mg from Remy Peptides?
Yes. Remy Peptides lists TB-500 10mg Vial as in stock for research-use-only orders in Dubai and the UAE. The live product page is the source of truth for current stock, AED pricing, and COA request details.
What format and price does Remy list for TB-500 10mg?
Remy Peptides lists TB-500 10mg as 10mg · Lyophilized research vial, with current AED tiers shown as AED 290-350. Prices, pack tiers, and orderability can change, so the product page should be checked before any research order.
What evidence does this TB-500 10mg guide cover?
This article summarizes compound identity, the strongest peer-reviewed evidence anchors, and the limits of translating regulated or preclinical findings to a research-use catalog vial. It is an evidence map, not a clinical-use guide.
Is TB-500 10mg sold for human or veterinary use?
No. Remy Peptides products are supplied strictly for in-vitro laboratory research. They are not for human use, veterinary use, diagnosis, treatment, cure, disease management, or personal-use protocols.
Which page should researchers use next?
Use /product/tb-500-10mg for the live product facts, price tier, stock status, image, and COA route. Use the linked Remy research profile or comparison article for deeper mechanism and evidence context.
Sources
- Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends in Molecular Medicine. 2005. PMID: 16099219 ↑
- U.S. National Library of Medicine. ClinicalTrials.gov search results for RGN-259 / thymosin beta-4 ophthalmic studies. clinicaltrials.gov ↑
For current stock, pricing, and COA route, use the live TB-500 10mg Vial page. For wider supplier verification, continue to the peptide COA guide and official contact verification.